Creator: Dr. Tran Le, MD, DABOM
Published: 2026-06-18T13:54:15+00:00

If you've worked hard to lose weight on a GLP-1, one question tends to keep you up at night: What happens when I stop? We discuss the honest answer with patients before they ever taper off. This post covers what the science shows about maintaining weight after GLP-1 treatment and the physician-led approach we use to protect your progress.

What happens to your weight after stopping a GLP-1

When people stop GLP-1 medications, the weight tends to come back, often a lot of it.

A large 2026 systematic review found that after stopping semaglutide or tirzepatide, the average weight regained in the first year was 9.9 kg. The same analysis projected that participants returned to their baseline weight roughly 1.5 years after stopping.

In the well-known STEP 1 trial extension, one year after withdrawal of once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, participants regained two-thirds of their prior weight loss, with similar changes in cardiometabolic variables.

This isn't a willpower failure. It's biology. Weight regain is driven by adaptive physiological responses (such as increased ghrelin, reduced leptin, lower peptide YY levels, and decreased energy expenditure) that promote appetite and energy conservation.

When you lose weight, your body pushes back with stronger hunger signals and a slower metabolism. Stopping the medication that was quieting those signals lets them return.

Why this happens: obesity is a chronic disease

Obesity behaves like other chronic conditions. You wouldn't expect blood pressure to stay normal after stopping a blood pressure medication, and weight works similarly.

The STEP 1 extension authors noted their findings confirm the chronicity of obesity and suggest ongoing treatment is required to maintain improvements in weight and health. The federal government frames it the same way. Obesity is a chronic disease that affects more than 4 in 10 adults in the United States, and nearly 1 in 10 Americans have severe obesity.

The FDA has approved several weight-management drugs for long-term use: orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound).

That removes the pressure to "finish" treatment by an arbitrary deadline. The goal is durable health.

How to maintain your results: a physician-led plan

Dr. Tran Le, MD, DABOM, approaches maintenance this way with patients. She is triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine.

1. Build all four pillars

Medication is one tool. The Obesity Medicine Association describes four pillars of obesity treatment: nutrition therapy, physical activity, behavioral counseling, and medical interventions. Patients who maintain best build these habits while on medication, so the foundation is in place if a dose ever changes.

Two pillars matter most for maintenance: protein-forward nutrition and resistance training. Early and lifelong treatment is critical for maintaining lean body mass as well as preventing weight recurrence and increased adiposity. Obesity treatment should reduce adiposity, preserve lean muscle, and maintain bone health. Protecting muscle keeps your metabolism higher and makes regain harder.

2. Consider a maintenance dose instead of a full stop

For many patients, the goal is the lowest effective dose that holds the weight steady, not stopping entirely. One 2026 meta-regression concluded that adopting an individualised dose-tapering approach can limit weight regain, but more research is needed to develop strategies for reliable long-term maintenance after GLP-1RA cessation.

3. Plan the transition

If you need to pause (cost, supply, pregnancy planning, a procedure), do it with a plan and clinical support. Oxford researchers studying medication withdrawal emphasized the value of wraparound behavioural support for people who stop these medications. A scheduled check-in, a clear nutrition and activity plan, and an agreement on when to re-evaluate all help.

From that same team: 'The question isn't whether these medicines work, they clearly do,' said the lead researcher. The challenge is durability.

If you need to bridge a gap in coverage, our Medicare GLP-1 bridge and flexible membership options keep care continuous.

Frequently asked questions

Will I gain all the weight back if I stop my GLP-1?

Not necessarily, but the risk is real. Studies show most people regain a significant portion of lost weight within the first year after stopping, largely because hunger and metabolism signals rebound. A planned taper, strong lifestyle habits, and ongoing follow-up reduce that risk.

Do I have to take a GLP-1 forever?

Not always. Obesity is a chronic condition, so many people benefit from long-term treatment, sometimes at a lower maintenance dose. We decide the right duration together based on your health, goals, and response. This article is educational and isn't a substitute for personalized medical advice.

Is a maintenance dose lower than my full dose?

Often, yes. The aim is the smallest dose that holds your results steady while minimizing side effects and cost. Always taper with your prescriber, not on your own.

Start with a plan that lasts

Our telehealth practice serves patients across Texas and Utah with physician-led care reviewed by Dr. Le. We offer all-inclusive compounded semaglutide and tirzepatide memberships and an à la carte plan for brand-name GLP-1s. (Compounded medications are not FDA-approved.) See how it works or start your consultation.

Maintaining Weight After GLP-1: What Really Works